Business Wire (Free subscription) | 10/06/2008
SEATTLE--(BUSINESS WIRE)--ZymoGenetics, Inc. (NASDAQ: ZGEN) announced today that Douglas E. Williams, Ph.D., President and Chief Scientific Officer, will provide an update on company
The Puget Sound Business Journal (Free subscription) | 09/18/2008
Dutch biotech ProFibrix B.V. said it’s opening a wholly owned subsidiary in Seattle, which will be led by a former ZymoGenetics Inc. executive. (ZGEN)
Business Wire (Free subscription) | 09/16/2008
SEATTLE--(BUSINESS WIRE)--ZymoGenetics, Inc. (NASDAQ:ZGEN) announced today that James A. Johnson, Executive Vice President and Chief Financial Officer, will provide an update on company
advanced nanotechnology (Free subscription) | 09/11/2008
1. Financial market graphs can be mined using dwave's quantum computers The dark blue shows that the solution is saying that a diversified portfolio would be Google, ZymoGenetics, Yahoo, Affymetrix and Microsoft. 2. Verifying whether a logic circuit performs to specifications is an important part of the circuit design process. These benchmark SAT problems were generated during formal hardware verification...
Red Orbit (Free subscription) | 09/03/2008
ZymoGenetics, Inc. (NASDAQ: ZGEN) today announced a restructuring of its partnership with Merck Serono, a division of Merck KGaA, Darmstadt, Germany. With respect to the ongoing development of atacicept, ZymoGenetics exercised its contractual right to convert to a worldwide royalty license.
Seattle Times (Free subscription) | 09/03/2008
Seeking to reduce the rate at which it burns cash, ZymoGenetics is handing off the development and commercialization of one of its key compounds...
The Puget Sound Business Journal (Free subscription) | 09/02/2008
As part of its deal with Bayer Health Care, ZymoGenetics Inc. said it will receive a $5 million milestone payment from the German health-care company. (ZGEN)
Business Wire (Free subscription) | 09/02/2008
SEATTLE--(BUSINESS WIRE)--ZymoGenetics, Inc. (NASDAQ:ZGEN) announced today that Douglas E. Williams, Ph.D., President and Chief Scientific Officer, will provide an update on company
Business Wire (Free subscription) | 09/02/2008
SEATTLE--(BUSINESS WIRE)--ZymoGenetics, Inc. (NASDAQ:ZGEN) announced today that it will receive a $5 million milestone payment from Bayer HealthCare, which was triggered by the
Seattle Times (Free subscription) | 08/30/2008
Pacific Northwest ZymoGenetics said Friday it has sold a parcel of land next to its Eastlake headquarters for net proceeds of $11.5 million million. The buyer...
Seattle Times (Free subscription) | 08/29/2008
ZymoGenetics said Friday it has sold a parcel of land next to its Eastlake headquarters for $11.5 million to a buyer apparently affiliated with Alexandria Real Estate Equities.
Slog (Free subscription) | 08/28/2008
King County has rolled out its Green Bikes Project (GBP), a partnership between the county, the Cascade Bicycle Club, REI and local businesses to cut down on car commuting. The GBP will provide 200 Novar bicycles to employees at partner companiesFoss Maritime, Expedia, Zymogenetics, Perkins Coie, Boeing, REI, Swedish Hospital and otherwho commit to riding to work through May 2009. Companies must...
Seattle Post-Intelligencer (Free subscription) | 08/06/2008
ZymoGenetics said it sold $1.4 million of its first drug during the second quarter, far below analysts' expectations, as the company continued its push to break into the market for treatments to control bleeding during surgery.
Seeking Alpha (Free subscription) | 08/06/2008
ZymoGenetics Inc. (ZGEN) Q2 2008 Earnings Call Complete Story »
Red Orbit (Free subscription) | 08/06/2008
ZymoGenetics, Inc. (NASDAQ:ZGEN) today reported its financial results for the second quarter ended June 30, 2008. The company reported a net loss for the quarter of $37.4 million, or $0.54 per share, compared to a net loss of $37.3 million, or $0.55 per share, in the prior year quarter.
